Board logo

subject: Aarkstore Enterprise -global Biotech Market Analysis And Forecasts, 2008-2023- Market Research Aggr [print this page]


 Aarkstore Enterprise -global Biotech Market Analysis And Forecasts, 2008-2023- Market Research Aggr

Global Biotech Market Analysis and Forecasts, 2008-2023

Includes Top 10 Therapy classes for biotech

Also Top 10 products in the biotech sector

The biotechnology industry is a major growth area in the global healthcare market, one upon which many companies are placing their hopes. Due to developments in monoclonal antibodies, genomics and proteomics - amongst others - the biotechnology market has experienced great expansion since its emergence during the 1970s. The leading biotechnology company, Amgen, is now amongst the largest pharmaceutical companies in the world, with other biotechnology companies catching up. The global biotech drug market was worth over $75bn in 2007, with double-figure growth noticeably higher that that of the overall pharmaceutical market.

Increased R&D efforts, shorter approval times and innovative new treatments are aiding market growth. However, the two major threats the healthcare biotechnology sector faces in the coming years are the increasing threat of biogenerics and the difficulty in acquiring capital. Strategic partnerships will continue to be important to biotechnological drug development.

This brand new report - Global Biotech Market, 2008-2023- examines the healthcare biotech market critically, through comprehensive research and analysis. This report covers both the top ten therapy classes as well as the top ten leading pharmaceutical products in the biotech market in particular, as well as leading pipeline agents. The result is a comprehensive market-based report with detailed analysis and informed opinion.

You will not find this information available anywhere else.

Why you should buy this report:

In particular, our Global Biotech Market, 2008-2023 report concentrates on the following essential aspects of that market, including the competitive environment for original branded products and biogenerics:

Detailed analysis of the global biotech market, including an overall market sales forecast for 2008-2013, 2018 and 2023

Sales forecasts for leading products and therapeutic areas for 2008-2013, 2018 and 2023

Discussions of issues affecting the market segments, including SWOT analysis

Drivers and opportunities in the biotech industry

Restraints and threats facing the biotech industry

Discussion of the leading companies and their strategy in the context of the market

Pipeline developments and their implications for the future

Strategic alliances and licensing.

There are significant financial benefits from a companys having a portfolio of biotech drugs, especially in this very uncertain period, when technological and commercial change is accelerating. This realisation has caused the major pharmaceutical companies to establish themselves in the biotech market. At least half of the top ten pharmaceutical companies now have leading biotech drugs. Thinning developmental pipelines in small molecule agents can, in part, explain big pharma's embracing of the biotech market, forcing them to buy biotech firms with promising drugs in development. This report provides valuable commercial information on this exciting industry that no healthcare company should ignore.

For more information, please contact :

http://www.aarkstore.com/reports/Global-Biotech-Market-Analysis-and-Forecasts-2008-2023-33791.html

Contact : Minu

Aarkstore Enterprise

Tel : +912227453309

Mobile No: +919272852585

Email : contact@aarkstore.com

Website : http://www.aarkstore.com

Blog: http://blogs.aarkstore.com/

by: aarkstore enterprise




welcome to Insurances.net (https://www.insurances.net) Powered by Discuz! 5.5.0   (php7, mysql8 recode on 2018)